Lama Giuliana, Luongo Ilaria, Tirino Giuseppina, Borriello Adriana, Carangio Ciro, Salsano Maria Esposito
Department of Paediatrics, Second University of Naples, Italy.
Am J Kidney Dis. 2002 May;39(5):958-65. doi: 10.1053/ajkd.2002.32769.
We investigated lymphocyte subpopulations and the production of cytokines by T helper cell subtype 1 (Th1), Th2, and monocytes/macrophages (tumor necrosis factor-alpha [TNF-alpha]) in peripheral-blood mononuclear cells of 18 children with steroid-sensitive (SS) nephrotic syndrome (NS) and 10 children with steroid-resistant (SR) NS. Mean age was 10.9 +/- 5.7 years, with a mean follow-up before the study of 6 +/- 5 years. To evaluate the possible relationship between cytokine levels and response to treatment, patients with SS and SR NS were assessed during relapse/marked proteinuria (group A), total/partial remission (group B), and off treatment (group C). In children with SS and SR NS, we found no significant difference in CD3 counts compared with controls. The proportion of CD4 cells decreased significantly in relapse and off therapy compared with controls in children with SS NS, whereas in those with SR NS, there was a concomitant reduction in all groups. B-Lymphocyte counts were significantly increased in either group versus controls. In SR NS, CD8 and natural killer cell levels increased during relapse versus controls. The CD4+/CD8+ ratio was reduced to the same degree in those with SS and SR NS. In patients with SR NS, we observed increased levels of soluble interleukin-2 (IL-2) receptor (sIL-2R) from corresponding control values (P < 0.01). A significant increase in TNF-alpha levels was found in patients with SS and SR NS versus controls. High levels of IL-2, sIL-2R, and interferon-gamma during relapse in patients with SS NS give further evidence for a Th1 pattern that might be involved in the pathogenesis of NS, and monitoring the Th1/Th2 balance would be useful in evaluating the response to therapy.
我们研究了18例激素敏感型(SS)肾病综合征(NS)患儿和10例激素抵抗型(SR)NS患儿外周血单个核细胞中淋巴细胞亚群以及辅助性T细胞1型(Th1)、Th2和单核细胞/巨噬细胞(肿瘤坏死因子-α [TNF-α])产生细胞因子的情况。平均年龄为10.9±5.7岁,研究前平均随访时间为6±5年。为评估细胞因子水平与治疗反应之间的可能关系,在复发/明显蛋白尿期(A组)、完全/部分缓解期(B组)和停止治疗期(C组)对SS和SR NS患者进行了评估。在SS和SR NS患儿中,与对照组相比,我们发现CD3计数无显著差异。与对照组相比,SS NS患儿在复发期和停止治疗时CD4细胞比例显著降低,而SR NS患儿在所有组中均有相应降低。与对照组相比,两组的B淋巴细胞计数均显著增加。在SR NS中,复发期与对照组相比,CD8和自然杀伤细胞水平升高。SS和SR NS患者的CD4+/CD8+比值降低程度相同。在SR NS患者中,我们观察到可溶性白细胞介素-2(IL-2)受体(sIL-2R)水平较相应对照组升高(P<0.01)。与对照组相比,SS和SR NS患者的TNF-α水平显著升高。SS NS患者复发期IL-2、sIL-2R和干扰素-γ水平升高,进一步证明Th1模式可能参与NS的发病机制,监测Th1/Th2平衡有助于评估治疗反应。